AstraZeneca plc (AZN) Given "Buy" Rating at Deutsche Bank AG

AstraZeneca plc (AZN) Given "Buy" Rating at Deutsche Bank AG


's stock had its "buy" rating reiterated by equities research analysts at Deutsche Bank AG in a research note issued on Tuesday. They presently have a GBX 5,500 price objective on the biopharmaceutical company's stock.



from Biotech News